FDA commissioner joins W.Va. policymakers in opioid addiction discussion

The commissioner of the Food and Drug Administration, Robert Califf, MD, joined a panel of state leaders and physicians in Charleston, W.Va., on Tuesday to discuss the national opioid epidemic.

Advertisement

U.S. Senator Joe Manchin (D–W.Va.) who urged the FDA to take a more active role in fighting opioid addiction. Senator Manchin proposed requiring the agency to seek advice from an advisory committee before approving opioid medications. The FDA would have to provide justification to Congress when approving an opioid against the advice of the committee.

The panel also discussed implementing more education measures for prescribers and how to improve treatment for opioid addicts.

More articles on infection control and clinical quality:

Hormone therapy may cause tumor growth in some breast cancer patients
Scientists develop new MRSA treatment
3 challenges inhibiting EHR use for patient safety research

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.